WORLDWRAPFEDERATION.COM

IN THE STREETS & ON THE WEB

Tennis Star Serena Williams Reveals Why She Choose To Use Weight Loss GLP-1 Medication

Serena Williams just revealed she's taking a popular weight loss drug, Zepbound, a GLP-1 medication, admitting she first tried to do it naturally but nothing worked she about the decision surely to be polarizing after the tennis GOAT struggled to drop weight with just diet and exercise after giving birth to her second child in 2023. "My whole life is being in the gym, working out, running, training, HIIT training, dancing, every single thing you can think of," Williams said. "I would always get to a certain point on the scale, but I could never get below that. That’s when I decided that it was time to try something different and got on the GLP-1 with Ro if you're unfamiliar, is an online pharmacy where patients can access GLP-1 weight loss medications like Ozempic and Wegovy, in addition to Zepbound. "I would always get to a certain point on the scale, but I could never get below that. That’s when I decided that it was time to try something different and got on the GLP-1 with Ro. Williams who has continued eating healthy and working outfelt it was important to be transparent about her weight loss journey, which has been widely covered by the media. Serena also wanted to show solidarity with the many women who do the right things to lose weight, but just don't see the pounds fall off. "I was putting in the work. I actually think it’s a problem a lot of other women can relate to, that you are in the gym and eating healthy, but just can’t get to the level you want or need to," Williams said. "I feel lighter mentally, I feel sexier, I feel more confident.

SOURCE

Views: 11

Comment

You need to be a member of WORLDWRAPFEDERATION.COM to add comments!

Join WORLDWRAPFEDERATION.COM

Listen to Scurry Life Radio For Artist Placement On The Site Contact: R5420records@yahoo.com

© 2025   Created by WORLD WRAP FEDERATION.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Subscribe